This Medical News article discusses safety concerns around compounded semaglutide and tirzepatide, including how clinicians can help prevent dosing errors.

BACKGROUND: Women who had preeclampsia (a history of preeclampsia) have a >4-fold risk of developing cardiovascular disease compared with women who had an uncomplicated pregnancy (history of health...

Decades of recommendations to give aspirin for primary prevention of cardiovascular events, based on overoptimistic interpretation of inconclusive data, were recently overturned after a randomized cli...